even for mice that were immunocompromised. “Modified BCG elicited similar immune responses and provided similar protection against Mtb challenge as wild-type BCG in mice,” the investigators wrote.

Most clinically relevant T-cell receptor (TCR)-engineered T cells are typically tested in immunocompromised mice, allowing human T-cell engraftment but failing to replicate the complex interactions of ...